当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析

华恒生物

(688639)

  

流通市值:79.72亿  总市值:87.18亿
流通股本:2.28亿   总股本:2.50亿

华恒生物(688639)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.68亿元,每股收益0.74元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益185538.68万元,未分配利润108316.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产470424.01万元,负债284885.33万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,539,034,126.351,016,220,737.71500,781,373.591,938,268,117.78
营业总成本1,382,619,720.33870,509,300.9411,603,470.891,447,706,028.02
营业利润182,479,304.25163,413,402.9796,233,364.51510,903,260.37
利润总额184,110,755.53164,493,647.896,585,933.92506,270,942.2
净利润167,996,718.7147,992,111.9785,868,603.65446,599,806.18
其他综合收益-196,251.6588,915.7423,061.8281,725.54
综合收益总额167,800,467.05148,081,027.7185,891,665.47446,681,531.72
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,239,970,610.671,181,062,594.171,208,314,144.171,050,046,406.02
非流动资产合计3,464,269,466.493,311,454,582.063,178,907,913.852,920,191,687.28
资产总计4,704,240,077.164,492,517,176.234,387,222,058.023,970,238,093.3
流动负债合计2,052,065,663.022,020,127,544.631,942,839,115.521,676,478,602.46
非流动负债合计796,787,649.25638,908,731.05542,614,164.39468,098,715.66
负债合计2,848,853,312.272,659,036,275.682,485,453,279.912,144,577,318.12
归属于母公司股东权益合计1,858,594,150.651,836,506,921.051,903,784,686.211,826,971,175.81
股东权益合计1,855,386,764.891,833,480,900.551,901,768,778.111,825,660,775.18
负债和股东权益合计4,704,240,077.164,492,517,176.234,387,222,058.023,970,238,093.3
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,661,699,060.611,030,529,921.02513,500,222.862,097,788,655.78
经营活动现金流出小计1,557,092,432.25947,556,448.92616,915,968.411,796,371,440.43
经营活动产生的现金流量净额104,606,628.3682,973,472.1-103,415,745.55301,417,215.35
投资活动现金流入小计13,709,894.2610,583,4982,748,300214,515,285.73
投资活动现金流出小计645,115,987.17453,046,520.36201,073,326.451,341,564,990.51
投资活动产生的现金流量净额-631,406,092.91-442,463,022.36-198,325,026.45-1,127,049,704.78
筹资活动现金流入小计1,409,334,472.85833,371,849.62459,077,480.641,419,419,778.41
筹资活动现金流出小计799,377,753.45441,151,435.65142,473,770.11394,807,635.19
筹资活动产生的现金流量净额609,956,719.4392,220,413.97316,603,710.531,024,612,143.22
汇率变动对现金及现金等价物的影响9,654,463.178,317,616.573,069,171.516,540,841.69
现金及现金等价物净增加额92,811,718.0241,048,480.2817,932,110.04205,520,495.48
期末现金及现金等价物余额445,305,816.8393,542,579.06370,426,208.82352,494,098.78
最新报告期:2024-11-13
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
长江证券马太,魏凯,王岭峰0.871.462.112024-11-13
天风证券唐婕,张峰0.981.942.212024-11-07
山西证券王锐,冀泳洁0.941.241.642024-11-06
中金公司裘孝锋1.051.73--2024-10-30
浙商证券任宇超1.802.704.152024-10-29
TOP↑